A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination

Marco Ranzani; Kristel Kemper; Magali Michaut; Oscar Krijgsman; Nanne Aben; Vivek Iyer; Kim Wong; Theodoros I Roumeliotis; Martin Del Castillo Velasco-Herrera; Jérémie Nsengimana

A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination

Marco Ranzani, Kristel Kemper, Magali Michaut, Oscar Krijgsman, Nanne Aben, Vivek Iyer, Kim Wong, Theodoros I Roumeliotis, Martin Del Castillo Velasco-Herrera, Jérémie Nsengimana

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	195354
Number of pages	1
Journal	bioRxiv
Publication status	Published - 2017
Externally published	Yes

Cite this

@article{47215fbf77c74a828c994072986c7289,

title = "A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination",

author = "Marco Ranzani and Kristel Kemper and Magali Michaut and Oscar Krijgsman and Nanne Aben and Vivek Iyer and Kim Wong and Roumeliotis, {Theodoros I} and Velasco-Herrera, {Martin Del Castillo} and J{\'e}r{\'e}mie Nsengimana",

year = "2017",

language = "English",

pages = "195354",

journal = "bioRxiv",

publisher = "Cold Spring Harbor Laboratory Press",

}

TY - JOUR

T1 - A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination

AU - Ranzani, Marco

AU - Kemper, Kristel

AU - Michaut, Magali

AU - Krijgsman, Oscar

AU - Aben, Nanne

AU - Iyer, Vivek

AU - Wong, Kim

AU - Roumeliotis, Theodoros I

AU - Velasco-Herrera, Martin Del Castillo

AU - Nsengimana, Jérémie

PY - 2017

Y1 - 2017

M3 - Article

SP - 195354

JO - bioRxiv

JF - bioRxiv

ER -